Martingale Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
GCM
Martingale Asset Management's BLUE Position: Q4 2023 in Review
Martingale Asset Management sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 1,398 shares — an estimated $85K sold.
Martingale Asset Management first reported a position in BLUE in Q2 2016 and held it in 22 quarters. The position peaked at $2.37M in Q4 2017. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.
- Martingale Asset Management reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
- Martingale Asset Management sold 1,398 bluebird bio shares in Q4 2023, an estimated $85K.
- Martingale Asset Management first reported a position in bluebird bio in Q2 2016 and held it in 22 quarters.
- Martingale Asset Management's bluebird bio position peaked at $2.37M in Q4 2017.
- 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.
Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.